Clinical Trial Update: Analysis of Circulating Tumor DNA Dynamics to Predict and Monitor Response to TKI in Patients With Advanced NSCLC.

View source ↗

Summary

This clinical trial registry entry describes a study evaluating circulating tumor DNA dynamics to predict and monitor response to tyrosine kinase inhibitors in …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Gene Solutions | Conditions: Non Small Cell Lung Cancer, Stage IIIB Non-small Cell Lung Cancer | Status: RECRUITING